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Abstract 
Introduction: Despite the availability of guidelines for the evaluation of candidates for renal 
transplantation, variation in access to transplantation exists. This national survey investigates 
whether centre variation exists in the assessment of patients for renal transplantation in the 
UK. 
Methods: An online survey, informed by qualitative interviews, was distributed to all UK 
renal centres. This survey examined centre approaches to chronic kidney disease service 
provision, transplant recipient assessment, education provision and wait-listing decision 
making processes. Centre re-evaluation policies for patients already listed and priorities for 
future development were also examined. 
Results: All 71 renal centres responded. Of these, 83% reviewed predialysis patients in a low 
clearance clinic. In 26% of centres transplantation was not discussed as a treatment option 
with all patients. Fourteen centres reported having a dedicated transplant assessment clinic 
whilst 28% did not have a formal assessment protocol. Age was an exclusion criterion for 
listing in 3 centers, all of which had a cut off at 75 years. 83% of centres excluded patients 
with a high BMI. Cardiac investigations were risk-stratified in 90% of centres. Surgical 
involvement varied with 11% of centres listing patients without formal surgical review. There 
was no formal protocol in place to re-evaluate listed patients in 62% of centres. 
Conclusions: There is wide variation in UK practice patterns for listing patients for renal 
transplantation, though its impact on access to transplantation is unclear. The extent to which 
centre-specific and patient-specific factors affect access to transplantation requires further 
analysis in a prospective cohort of patients. 
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Introduction 
It is widely regarded that for „suitable‟ patients with end stage renal failure (ESRF), renal 
transplantation confers both better quality of life and life expectancy than dialysis and is the 
preferred modality of renal replacement therapy (RRT)
1-4
. In light of these benefits, achieving 
prompt and timely activation on the transplant waiting list is important not least because 
increasing length of time on dialysis adversely affects graft and patient survival
5
, but also 
because organ allocation algorithms in many countries (including the UK) give priority to 
those who have spent greater time on the waiting list when allocating deceased donor 
kidneys
6-7
. Thus, centres that achieve earlier listing for transplantation may provide an 
advantage for their patients compared with centres that take longer.  
Various guidelines on the timing of referral for renal transplantation are available from 
professional organisations across the world
8-10
. Guidelines from the United States Organ 
Procurement and Transplantation Network (OPTN) Minority Affairs Committee state that the 
goal for referral should be that all potential candidates are referred for transplant at an 
estimated glomerular filtration rate (eGFR) above 20 ml/min/1.73m
2
 to favour early 
transplantation and avoid the development of comorbidities associated with dialysis as well 
as allowing patients to accrue waiting time that increases their chance of being allocated a 
donor organ
8
. In comparison the UK Renal Association guidelines recommend that patients 
with progressive deterioration in renal function suitable for transplantation should be placed 
on the national transplant list within 6 months of their anticipated dialysis start date and that 
preemptive transplantation should be the treatment of choice for all suitable patients 
whenever a living donor is available
10
. 
The term „suitable‟ used in these guidelines often poses a conundrum for clinicians as 
objective criteria to confirm suitability for transplantation are not clearly defined and hence 
are open to interpretation. To assist this process guidelines for the evaluation of candidates 
for renal transplantation have been published by the American Society of Transplantation
11
, 
the European Renal Association and European Society for Organ Transplantation
12
, the UK 
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Renal Association
10
, the British Transplantation Society
13
 and Caring for Australasians with 
Renal Impairment
14
. Despite the availability of clinical guidelines, significant variations in 
the assessment practices among transplant centres have been reported in the United States as 
well as Europe
15-17
.  
To explore this further we undertook a national survey as part of the NIHR funded Access to 
Transplantation and Transplant Outcome Measures (ATTOM) programme to examine 
whether variation exists in the organisation of renal services in listing patients, and to 
describe centre practices in the education and the evaluation of potential transplant recipients 
as well as exploring how decisions are made in the UK. 
Materials and Methods 
A structured online and paper-based survey consisting of 96 questions was developed using 
the results of 2 qualitative studies carried out within the ATTOM programme
18,19
. Qualitative 
studies included 53 patients and 42 healthcare professionals, and explored patients‟ views and 
experiences of joining the transplant waiting list and staff members‟ experiences of listing 
patients for transplantation. Staff and patients were recruited from a purposive maximum 
variation sample of 9 renal units in the UK. Existing published literature was also reviewed 
and feedback sought and incorporated from a group of experts on the ATTOM steering 
group. Pilot face-to-face interviews with 4 clinicians were conducted using the first draft 
survey to guide revision to improve instrument face and content validity and usability prior to 
distribution.  
The questionnaire was designed to establish the practice patterns of the unit relating to listing 
patients aged <75 years for transplantation. Once finalised, both versions (online and paper-
based) of the survey were sent to the lead physicians and surgeons of all 71 adult renal 
centres in the UK in January 2014. Clinicians were invited either to complete the survey 
personally or to nominate a representative within the unit to respond. It was specified that the 
respondent's answers should reflect current practice in the unit rather than individual 
preference.  
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Statistical analyses were performed using SAS version 9.3. Results for each question were 
expressed as a percentage of the total number of centres responding to the question. We 
identified several factors a priori as „exposure‟ variables and tested for associations of these 
categorical variables with care processes using Chi squared test or Mann Whitney test. Given 
the potential for multiple testing and false positives we only report associations that were 
significant at p<0.01. In order to measure how much time renal staff were involved in 
transplantation listing, Whole-time equivalent (WTE) time was asked. An WTE of 1.0 
indicates that a person is equivalent to a Whole-time worker, or 2 persons working half-time.   
 
Results 
A completed survey was received from all 71 (100%) adult centres in the UK, of which 23 
were transplanting and 48 were nontransplanting renal centres. The reported roles of 
respondents were: Clinical Director (42.3%), Consultant Nephrologist (49.3%), Consultant 
Transplant Surgeon (2.8%) and „Other health professional‟ (5.6%). Forty centres (56.3%) 
completed the web-based version and 31 centres (43.7%) the paper version of the survey. The 
responding centres had a total of 6699 patients active on the UK transplant waiting list at the 
end of 2012 and reported a national workforce involved in listing patients for transplantation 
which comprised of 488 WTE Consultant Nephrologists, 113 WTE Transplant Surgeons, 57 
WTE Associate Specialists, 73 WTE Transplant Co-ordinators and 75 WTE Live Kidney 
Donor Nurses. The median number of Consultant Nephrologists was significantly greater at 
transplanting centres (8.5; IQR 8-11) compared with nontransplanting centres (4.5; IQR 3-6), 
p<0.001).  
 
Chronic Kidney Disease Workforce and Organisation 
Almost 48% (47.9%, n=34) of centres reported seeing all predialysis patients in a dedicated 
low-clearance clinic (LCC), whilst 33.8% (n=24) of centres used a LCC for some of their 
patients. The remaining 18.3% (n=13) of centres did not have a designated LCC service. 
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There was no significant difference between nontransplanting and transplanting centres in 
terms of the pattern of LCC utilisation.  
LCCs were mostly joint (consultant with nurse, 48.3%) or consultant-led (43.1%), with only 
8.6% of centres having a nurse-led service. When LCCs were present, 30% of 
nontransplanting centres did not have a specified protocol for referral for transplantation 
compared with 11.1% of transplanting centres (p<0.001). 
 
Transplantation Education 
Transplantation was discussed as a treatment option with all patients under the age of 75 in 
51 (71.8%) of centres, with other centres reporting a more selective policy. The decision not 
to discuss was made mostly by a consultant led multi-disciplinary team (MDT) (55%) or 
solely by a consultant nephrologist (40%). Discussions regarding transplantation were led 
most often by a consultant nephrologist (64.8%), with nurses leading the discussion in 19.7%, 
transplant surgeons in 2.8% and „other‟ healthcare professionals in 12.6% of centres. Despite 
reporting a wide range of educational delivery tools, education almost always took the form 
of a one-to-one consultation (98.6%) where patients were given literature to take home to 
read (91.5%).  
 
Transplant Listing Pathway and Role of Transplant Surgeons 
The clinical setting for transplant assessment varied, with 36.4% of centres utilising a LCC, 
21.2% seeing patients in their usual CKD clinic and 19.7% utilising a specific transplant 
assessment clinic. The remaining 22.7% of centres reported a mix of „other‟ clinical settings. 
The use of specific transplant assessment clinics was similar in nontransplanting centres and 
transplanting centres, though the frequency varied widely, with clinics occurring monthly or 
less frequently in 55% of nontransplanting centres, as compared with 100% of transplanting 
centres running these clinics fortnightly or more frequently, p<0.001. Overall 88.2% (n=63) 
of centres required all patients to be seen by a Transplant Surgeon prior to being listed; of the 
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remaining 8 centres that did not require direct surgical review, 4 centres (1 transplanting and 
3 nontransplanting) reported that all patients were discussed with a Transplant Surgeon, 
whilst 4 centres reported no surgical involvement in the decision to list for transplantation. 
 
The Assessment Process 
Nationally 30% (n=21) of centres did not have a written transplant work-up protocol for 
recipient assessment, which included 3 transplant centres. Figure 1 shows the frequency with 
which different investigations were used for the routine assessment of potential renal 
transplant recipients amongst the 71 centres. Three nontransplanting centres reported having 
an upper age limit of 75 years (above which patients were only considered in exceptional 
circumstances for transplantation) whilst all other centres (n=68, 95.6%) did not report any 
age restrictions. In comparison, Body Mass Index (BMI) was widely used as an exclusion 
criterion for listing patients, with 81.7% (n=58) of centres excluding patients for 
transplantation based on BMI. The overall median upper BMI cut off, in these centres was 35 
(IQR: 33.25-35), with 36 centres reporting an upper limit of 35, and 5 centres an upper limit 
of 40 whilst the remaining 17 centres stated a BMI limit between 33-30. The reasons stated 
for using BMI as an exclusion criterion are summarised in Table 1. These did not differ 
between centres other than perceived increased cardiovascular risk, which appeared to be 
more of an issue for nontransplanting (52.5%) than transplanting centres (33.3%), p<0.01. 
All transplanting centres, and 87.5% (n=65) of nontransplanting centres reported stratifying 
patients by risk when deciding which cardiac investigations to perform. Age (median 50 
years; IQR: 50-55)(88%), diabetes (97%), previous cardiovascular disease (91%), and an 
abnormal ECG (89%) were used to determine risk. Thirty-one centres (44%) conducted some 
form of „cardiac stress testing‟ even in low risk patients whilst significant variation was seen 
in the first-line investigation of choice for the assessment of coronary artery disease in high 
risk patients (Table 2). If a coronary angiogram was deemed necessary for listing a low 
clearance patient, 5.6% (n=4) of centres reported they would refrain from performing the test 
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until patients were on dialysis to avoid precipitating the need for dialysis, with a further 
74.6% stating they would „sometimes‟ refrain from proceeding. Only 19.7% reported always 
proceeding.  
Variation was also seen in screening for malignancies with 38% of centres reporting that 
screening for cancer such as breast, prostate, bladder and colorectal was part of the routine 
work-up of transplant recipients, in addition to national screening programmes. In contrast, 
formal psychological or cognitive assessment of all potential recipients was only performed 
in 7.0% and 5.6% of centres respectively, with 13.1% of centres reporting no access to 
psychologist or counsellor services. 
 
Decision Making  
Overall 76.1% (n=54) of centres utilised an MDT approach when listing patients for 
transplantation. This proportion was greater amongst transplanting centres where all but one 
center (95.7%) used an MDT, compared to 66.7% (n=54) in nontransplanting centres. MDTs 
occurred more frequently in transplanting centres with a median of 4 meetings a month (IQR 
1.25-4) as compared to 2 a month (IQR 1-4;p= 0.001) in nontransplanting centres.   
If a patient was not deemed suitable for listing for deceased donor transplantation, 76.1% of 
centres said that they would consider listing them for living donor transplantation if a suitable 
donor was available. Living donor availability was generally seen as a positive driver for 
listing, alongside patient enthusiasm, whilst the majority of centres did not perceive 
socioeconomic factors, including employment status or level of patient education, as 
important when deciding whether to list patients for transplantation (Figure 2).  Once a 
decision regarding listing was made, 50.7% of centres reported informing all patients on 
dialysis, or with CKD stage 5 under 75 years, of the decision, with 78.6% of centres 
recording all decisions made on transplant suitability on their electronic patient record (EPR). 
Once recorded on their EPR, only 61.8% of centres performed regular audit of this 
information.  
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After listing, only 38% of centres reported having a protocol in place to monitor patients 
activated on the transplant list with the majority of centres (53.5%) reviewing patient 
suitability annually. Significant variation existed in how centres undertook on-going 
surveillance for cardiac disease in asymptomatic patients once listed as shown (Table 3). This 
was also highlighted in centres‟ responses to questions on improving listing, with 53 centres 
(74.6%) either agreeing or strongly agreeing with the need for having a national consensus on 
cardiac work up, and 52 centres (73.2%) also agreeing that there was a need for a consensus 
on the entire assessment work-up process (Figure 3). 
 
Inter-Centre Relationships and Future Development 
Although 95% of centres reported having a positive relationship with a „good‟, „very good‟ or 
„excellent‟ relationship with their associated transplanting/nontransplanting centres, one third 
(n=16) of nontransplanting centres felt that accessing an appointment at their affiliated 
transplanting centre was a significant source of delay in listing patients. 
Factors reported by centres to be most important in improving listing of patients for 
transplantation included: providing a better evidence base behind necessary assessment work 
up; improving the commissioning of transplant work up by funders of the service; and 
developing a national consensus on the work up of transplant recipients (Figure 3). If extra 
funding was available, centres stated they would use this to increase the number of transplant 
co-ordinators and living-donor nurses, increasing the number of operation time slots for 
transplantation in trusts, and providing administrative support for allied health professionals 
involved in transplantation would likely improve overall listing and time to listing in their 
centres (Figure 4). 
Discussion  
This study provides the most extensive exploration to date of clinical practice patterns within 
renal centres in listing patients for renal transplantation in the UK; and is the first to account 
for practice patterns in both transplanting and nontransplanting centres. It provides a 
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comprehensive overview of the transplant-listing pathway including staffing levels, clinic 
arrangements, provision of patient education on transplantation, decision-making, recipient 
assessment, surgical review, criteria for listing, and the role of MDTs. 
For a national population of 64.1 million
20
 the number of consultant transplant surgeons 
reported (1.76 per million population) (pmp) in this survey remains significantly lower than 
the 2pmp recommended by the Royal College of Surgeons of England
21
. Indeed the number 
of consultant nephrologists (7.61pmp), transplant co-ordinators (1.14pmp) and living-donor 
nurses (1.17pmp) are all significantly lower than that recommended by the National Renal 
Workforce Planning Group and point towards an understaffed service
21
.  
Despite the UK Renal Association recommending that CKD patients pre RRT should be 
managed in a dedicated clinic by a MDT
22
, this study also demonstrated wide variation in the 
utilisation of low-clearance clinics nationally, with variation also seen in their 
implementation and entry criteria. There are many studies, albeit small, which have shown 
that a dedicated predialysis clinic is associated with improved outcomes and reduced urgent 
initiation of dialysis
23-26
. These clinics may provide focused opportunity to assess 
transplantation potential and more timely discussion of options including live donation and 
preemptive transplantation. Similarly, specific transplant-assessment clinics (used by a fifth 
of centres) enable joint assessment by physician and surgeon; whilst the evidence of their 
effectiveness is lacking they may be more efficient at transplant listing.  
Irrespective of the type of CKD service in place, a broad range of educational methods were 
utilised across the UK, with one-to-one education being the main route.  A significant 
proportion of centres (28%) did not discuss transplantation as a treatment option with all 
patients under the age of 75 years, and nearly 50% of patients who had had a decision made 
about them regarding transplantation were not informed of the decision made. This is of 
concern, as a patient-centred approach would require that all options are communicated to a 
patient and their family where possible. There may be exceptional circumstances where this 
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may not always be feasible, but such instances would be expected to be less frequent than 
was reported in the present study. 
Another important observation from this study was that some centres did not consider 
surgical review to be an absolute requirement for listing patients for transplantation. Eight 
centres listed without formal review, 4 of which cited no surgical involvement at all. The UK 
Renal Transplant Service specification stipulates that patients should undergo surgical 
assessment prior to being placed on the transplant list
27
, however it should be noted that in 
the US it is not uncommon to have only a subset of patients evaluated by transplant surgery 
in a face-to-face encounter. Instead, they selectively evaluate higher risk patients, e.g., those 
with vascular disease. 
Whilst in these centres it might be perceived that informed consent need not be taken by a 
surgeon and can instead be obtained by an experienced physician. The authors question 
whether without surgical input, patients can truly make an adequately informed choice and be 
involved in shared decision-making about transplantation and the associated surgical risks. 
Chronic understaffing described earlier and the belief that surgical evaluation of every patient 
prior to listing might reduce/delay access to transplant, may partly explain why centres have 
adopted such practices, though its impact on outcome is not known.  
Several national guidelines recommend that centres should have written criteria for 
acceptance of patients onto the waiting list
10, 28
, yet nearly a third of centres reported not 
having a protocol, including 3 transplanting centres. The lack of standardisation in these units 
could lead to variation in assessment, stereotyping, individual clinician bias and personal 
idiosyncrasies contributing to inequity. It was reassuring that the majority of centres (95.6%) 
did not use chronological age per se as an exclusion criterion. This figure is higher than that 
seen in the US, where 66% of centres reported having an upper age cut-off (in a similar study 
of transplanting centres)
29
, and acknowledges the notion that age must not be used as a proxy 
for the assessment of individual need and suitability. It also highlights how clinicians are 
aware that chronological age can be very different to biological age in different individuals, 
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and how assessment needs to be tailored on a case-by-case basis to avoid unwarranted age 
discrimination.  
In contrast to age, the majority of centres used BMI as an exclusion criterion, similar to 
findings from studies from the US
30
, Canada
31
 and Europe
32
, with a wide upper BMI limit of 
30-40. In the context of an increasingly obese population, such a broad range has the 
potential to cause variation in access to transplantation.  Obese patients are certainly at an 
increased risk of technical difficulties and peri-operative complications
33-34
 though evidence 
in favour of imposing a BMI limit on the basis of more hard end-points (patient and graft 
survival) is conflicting
35-40
. A number of reports from nationwide databases, including the 
USA, Australia and the Netherlands
35, 38, 40
, have shown decreased patient and graft survival 
in obese recipients, whilst others showed no differences in survival between obese and 
nonobese transplant recipients
39
. It is unclear in studies where an increase in risk was noted, 
how much would be mitigated once co-existing cardiovascular disease was accounted for. 
This raises the notion that if technically feasible, and cardiovascular disease has been ruled 
out, most patients should be considered for transplantation irrespective of their BMI. 
As cardiovascular disease remains the main cause of death in transplant recipients
41
, it is 
unsurprising that most centres invest a great deal of time and resource in its investigation and 
management. This study showed that most centres stratify patients on their level of risk, 
though the choice of ensuing investigation varied greatly with no clear consensus irrespective 
of risk, from noninvasive functional tests to invasive angiography. This variation is likely due 
to a combination of factors including lack of evidence on superiority for any one 
investigation, as well as local cardiac service availability and experience. Centres also 
differed in their perception of risk associated with angiography in low-clearance patients. 
Overall this variation has the potential for creating inequity, as centres adopting more intense 
screening protocols might impede wait-listing for patients with barriers to getting the tests 
completed. 
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Another important issue which needs mentioning is the cost implications of changing practice 
patterns, particularly at a time of receding budgets and rising concern over the cost and value 
of healthcare. Indeed, it is likely that individual centre practices are in part, a consequence of 
local infrastructure and availability of service providers, and though instigating some changes 
may be relatively inexpensive e.g. introducing a written protocol, others e.g. introducing 
universal invasive cardiac screening for coronary artery disease, may require significant 
expenditure. Acknowledging this, prior to recommending significant changes to centre 
practices, it is pertinent to demonstrate the medical efficacy and cost-effectiveness of any 
proposed changes on access to transplantation which will also assist in ensuring they are 
long-lasting. 
Limitations 
Although this study received a 100% response rate across all parts of the UK and though the 
survey instrument was piloted and refined to enhance relevance, understandability, and 
usability; some limitations need to be acknowledged. The survey responses were self-
reported by self-selecting renal staff e.g. the clinical lead for transplantation, and their 
responses will not necessarily reflect those of the broader consultant community. Likewise, as 
only a small proportion (2.8%) of respondents identified themselves as being a transplant 
surgeon this may have potentially biased the results due to the under-representation of 
surgical opinion amongst responders. Equally, we could not check the validity of responses 
garnered and some of these data were necessarily estimates and so should be regarded with 
caution. There may also have been a social desirability bias in the responses as respondents 
may have answered questions to put their centre in a good light. Furthermore, most questions 
in the survey were multiple-choice questions that invited respondents to select the best 
possible answer out of the choices available. This approach necessarily limits their responses, 
although an option to select "other" was provided and the survey was designed following 
detailed qualitative interviews with patients and staff to identify core domains.  
In conclusion there is wide variation in UK practice patterns in listing patients for renal 
AC
CE
PT
ED
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
16 
 
transplantation. Potential causes for this are likely to include variation in international 
guidelines and a lack of consensus in evaluating patients especially assessing their 
cardiovascular risk
10-14, 28
. Differing local population co-morbidity and socioeconomic factors 
may also be playing a role alongside varying physician attitudes and beliefs towards 
transplant listing and risk assessment
42
. Future research should be directed at developing a 
national consensus on recipient work up and in understanding the utility of cardiovascular 
screening in potential transplant recipients, as well as gaining better long-term outcome data 
on the impact of obesity and age on transplantation. 
There is also a need to understand the impact, if any, of this variation on access to 
transplantation. In the UK, as part of the NIHR funded ATTOM study, patient variables and 
the impact of centre variables described in this study, will be further evaluated in a multilevel 
hierarchical model, in a prospective sample of incident dialysis patients recruited as part of 
the ATTOM Study. 
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Figure Legends: 
 
Figure 1: Bar chart showing proportion of UK Centres performing each investigation as part 
of their routine assessment of patients under consideration for renal transplantation wait 
listing at UK renal centres. 
 
Figure 2: Bar chart showing distribution across renal units of responses to the question: 
“Please indicate your views on whether the following factors influence the decision to 
list a patient” Please indicate how strongly each would influence a decision. Values are 
expressed as percentage of units (n=71). 
 
Figure 3: Bar chart showing distribution across renal units of responses to the question: 
“What is your opinion on the following statements about whether they would improve 
listing of patients for transplantation?” Please indicate how strongly you agree or disagree 
with each of the following.” Values are expressed as percentage of units (n=70).  
 
Figure 4: Bar chart showing distribution across renal units of responses to the question: 
“What is your opinion on whether more funding for the following resources would 
improve overall listing and time to listing in your unit? Please indicate how strongly you 
agree or disagree with each of the following.” Values are expressed as percentage of units 
(n=70).  
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Table 1: Reasons for considering raised BMI as a contraindication for 
transplantation by centres adopting a maximum exclusion criterion 
 
    Transplanting Centre NonTransplanting Centre Overall Nationally 
    N % (of Centres) N  % (of Centres) N % (of Centres) 
Increased postoperative 
complication risk 
16 88.9 34 85 50 86.2 
Increased technical 
difficulty in performing 
procedure 
14 77.8 30 75 44 75.9 
Increased cardiovascular 
risk 
6 33.3 21 52.5 27 46.6 
Lower Graft survival 
compared to a normal BMI 
6 33.3 9 22.5 15 25.9 
Lower patient survival 
compared to normal BMI 
6 33.3 9 22.5 15 25.9 
Other (please specify) 2 11.1 10 25 12 20.7 
Total   50   113   163   
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Table 2: First-line investigation of choice for the assessment of coronary artery 
disease in high-risk patients 
 
    Transplanting Centre 
NonTransplanting 
Centre Overall Nationally 
    N % (of Centres) N  % (of Centres) N 
% (of 
Centres) 
Exercise Tolerance Test 
5 
21.7 
1
0 
20.8 
1
5 
21.1 
Thallium Stress Test 
7 
30.4 
1
7 
35.4 
2
4 
33.8 
Stress Echocardiography 2 8.7 7 14.6 9 12.7 
Dobutamine Stress Tc 
Scan 
3 
13.0 
6 12.5 9 12.7 
Coronary Angiography 1 4.3 2 4.2 3 4.2 
CPEX Testing* 1 4.3 2 4.2 3 4.2 
Other (please specify) 4 17.4 4 8.3 8 11.3 
*Cardio-Pulmonary Exercise Test 
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Table 3: Continued surveillance of cardiac disease in asymptomatic patients on the 
waiting list reported across UK renal centres 
 
 
    Transplanting Centre 
NonTransplanting 
Centre Overall Nationally 
    N % N  % N % 
No routine surveillance if 
asymptomatic 
6 26.1 13 27.1 19 26.8 
All patients screened 
irrespective of remaining 
asymptomatic 
4 17.4 16 33.3 20 28.2 
Surveillance only in high risk 
groups 
12 52.2 11 22.9 23 32.4 
Varies, no specific policy 1 4.3 8 16.7 9 12.7 
Other (please specify) 0 0.0 0 0.0 0 0.0 
Total   23 100.0 48 100.0 71 100.0 
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